This MAPS webinar presents an overview of the current and near term Digital Therapeutics landscape and details real-world applications of Digital Therapeutics to illustrate potential in driving transformation of clinical practices to improve patient outcomes.
OVERVIEW
This series will provide you with tools to critically process and analyze medical scientific literature. You will get a good understanding of basic statistical concepts and theory that enable you to explain, understand and interpret data. These Webinars are practical and based on published articles and the analysis of these. You will work with the theory in practice to increase your understanding of the strengths and weaknesses of the statistics in scientific literature.
LEARNING OBJECTIVES – Part 2
Statistical analysis in clinical trials
–Null/alternative hypotheses
–Statistical assumptions (type I error, significance level, type II error, statistical power,)
–Hypothesis testing
–Statistical tests
Statistics used in RCTs
–Type of outcome measures (dichotomous, continuous, time-to-event)
–Statistics used for analysis of dichotomous data (relative risk, odds ratio, risk difference, NNT)
–Analysis of time-to-event variables (plotting and interpretation of Kaplan-Meier curves)
CLICK HERE TO VIEW IN THE COMMUNITY PORTAL
Not a MAPS Member but Want to View?
Membership is only $250 USD per year ($425 for a 2-year subscription) and includes access to all new live Webinars, all on-demand Webinars (over 50 Webinars and growing each month), discussion forums to share best practices and questions with over 4,000 Medical Affairs professionals from across the globe, copies of past meeting presentations, white papers, standards & guidance tools and templates, and much, much more. Click here for membership details or to sign up: https://medicalaffairs.org/membership/
Speaker:
Bruce Schechter
Early Access includes a variety of programs by which pharmaceutical companies make investigational therapies available to patients with life-threatening diseases. These patients have either exhausted available treatments or have no approved options. This presentation will review the processes and procedures to consider in the implementation of an Early Access Program and explore the opportunities and challenges posed therein.
Learning Objectives:
At the end of this webinar the participant will be able to:
CLICK HERE TO VIEW IN THE COMMUNITY PORTAL
Not a MAPS Member but Want to View?
Membership is only $250 USD per year ($425 for a 2-year subscription) and includes access to all new live Webinars, all on-demand Webinars (over 50 Webinars and growing each month), discussion forums to share best practices and questions with over 4,000 Medical Affairs professionals from across the globe, copies of past meeting presentations, white papers, standards & guidance tools and templates, and much, much more. Click here for membership details or to sign up: https://medicalaffairs.org/membership/
OVERVIEW
This series will provide you with tools to critically process and analyze medical scientific literature. You will get a good understanding of basic statistical concepts and theory that enable you to explain, understand and interpret data. These Webinars are practical and based on published articles and the analysis of these. You will work with the theory in practice to increase your understanding of the strengths and weaknesses of the statistics in scientific literature.
LEARNING OBJECTIVES – Part 1
CLICK HERE TO VIEW IN THE COMMUNITY PORTAL
Not a MAPS Member but Want to View?
Membership is only $250 USD per year ($425 for a 2-year subscription) and includes access to all new live Webinars, all on-demand Webinars (over 50 Webinars and growing each month), discussion forums to share best practices and questions with over 4,000 Medical Affairs professionals from across the globe, copies of past meeting presentations, white papers, standards & guidance tools and templates, and much, much more. Click here for membership details or to sign up: https://medicalaffairs.org/membership/
Speaker: John B. Pracyk, MD, PhD, MBA, FAANS, FACS
Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, DePuy Synthes – Spine, Johnson & Johnson Medical Devices Companies
The medical device industry is facing challenging times ahead. A broader set of influencers (regulators, hospital administrators and other value-orientated customers) will see a shift from individual outcomes to a focus on population-led effectiveness and will require the development of comprehensive value propositions for any device or drug.
In addition, sweeping reform of the rules that govern the medical device industry in Eu-rope represents one of the most disruptive changes to affect the global medical technology sector in recent times. Under the European Medical Device Regulation, companies will have three years to comply with a broad swathe of new rules for almost every kind of product in the medical device spectrum. How do medical device manufacturers deal with a decidedly more frugal and selective customer base? This webinar looks at serving the needs of all stakeholders by helping to ensure that the company gets safe, reliable products to market efficiently and cost-effectively—without any barriers to clearance.
Learning Objectives:
After participating in this Webinar, participants will be better able to:
CLICK HERE TO VIEW IN THE COMMUNITY PORTAL
Not a MAPS Member but Want to View?
Membership is only $250 USD per year ($425 for a 2-year subscription) and includes access to all new live Webinars, all on-demand Webinars (over 50 Webinars and growing each month), discussion forums to share best practices and questions with over 4,000 Medical Affairs professionals from across the globe, copies of past meeting presentations, white papers, standards & guidance tools and templates, and much, much more. Click here for membership details or to sign up: https://medicalaffairs.org/membership/